Canada markets close in 1 hour 13 minutes

Obalon Therapeutics, Inc. (OBLN)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
0.7900+0.0405 (+5.40%)
As of 2:46PM EDT. Market open.
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2019-12-31
2018-12-31
2017-12-31
2016-12-31
Total Revenue
2,603
3,281
9,101
9,914
3,393
Cost of Revenue
2,003
2,950
5,423
4,829
2,809
Gross Profit
600
331
3,678
5,085
584
Operating Expenses
Research Development
4,688
6,893
10,697
10,647
9,872
Selling General and Administrative
12,387
16,668
29,946
28,829
10,217
Total Operating Expenses
17,075
23,561
40,643
39,476
20,089
Operating Income or Loss
-16,475
-23,230
-36,965
-34,391
-19,505
Total Other Income/Expenses Net
-1,723
-61
-189
-239
-485
Income Before Tax
-18,068
-23,676
-37,380
-34,765
-20,467
Income from Continuing Operations
-18,068
-23,676
-37,380
-34,765
-20,467
Net Income
-18,068
-23,676
-37,380
-34,765
-20,467
Net Income available to common shareholders
-18,068
-23,676
-37,380
-34,765
-20,467
Basic EPS
-
-5.03
-19.60
-20.80
-48.50
Diluted EPS
-
-5.03
-19.60
-20.80
-48.50
Basic Average Shares
-
4,707
1,904
1,672
422.189
Diluted Average Shares
-
4,707
1,904
1,672
422.189
EBITDA
-
-22,336
-36,384
-34,061
-19,313